MedTrace Logo

An Observational Study of the Functional Capacity of Heart Failure

NCT02350114 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2016-07-01

No results posted yet for this study

Summary

This is an observational study of the functional capacity of patients with Heart failure with Reduced Ejection Fraction (HFrEF) who are admitted to the hospital for routine medical treatment.

Conditions

  • Acute Heart Failure

Interventions

PROCEDURE

6 Minute Walk Test

Evaluation of walking distance on standardized 6 minute walk test

Sponsors & Collaborators

  • Colorado Prevention Center

    collaborator OTHER

  • Cardioxyl Pharmaceuticals, Inc

    collaborator INDUSTRY

  • Bristol-Myers Squibb

    lead INDUSTRY

Principal Investigators

  • ShiYin Foo, M.D., PhD. · Cardioxyl Pharmaceiticals

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2015-05-31
Completion
2015-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02350114 on ClinicalTrials.gov